GRASr2 Evaluation of Aliphatic Acyclic and Alicyclic Terpenoid Tertiary Alcohols and Structurally Related Substances Used as Flavoring Ingredients by Marnett, LJ et al.
For Peer Review
 
 
 
 
 
 
GRASr2 Evaluation of Aliphatic Acyclic and Alicyclic 
Terpenoid Tertiary Alcohols and Structurally Related 
Substances Used as Flavoring Ingredients 
 
 
Journal: Journal of Food Science 
Manuscript ID: Draft 
Manuscript Type: 3 Concise Reviews and Hypotheses in Food Science 
Date Submitted by the Author: n/a 
Complete List of Authors: Marnett, Lawrence; Vanderbilt University, School of Medicine, Biochemistry 
Cohen, Samuel; University of Nebraska Medical Center, Pathology 
Fukushima, Shoji; Japan Bioassay Research Center,  
Gooderham, Nigel; Imperial College London, Surgery and Cancer 
Hecht, Stephen; University of Minnesota, Laboratory Medicine and 
Pathology 
Rietjens, Ivonne; Wageningen University, Toxicology 
Smith, Robert; Imperial College School of Medicine, Molecular Toxicology 
Adams, Timothy; Flavor and Extract Manufacturers Association,  
Bastaki, Maria; Flavor and Extract Manufacturers Association,  
Lucas Harman, Christie; Flavor and Extract Manufacturers Association,  
McGowen, Margaret; Flavor and Extract Manufacturers Association,  
Taylor, Sean; Flavor and Extract Manufacturers Association,  
Keywords: terpene tertiary alcohols, flavoring ingredients, FEMA GRAS 
  
 
 
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
GRASr2 Evaluation of Aliphatic Acyclic and Alicyclic Terpenoid Tertiary Alcohols and Structurally 1 
Related Substances Used as Flavoring Ingredients 2 
 3 
Larry J. Marnett, Samuel M. Cohen, Shoji Fukushima, Nigel J. Gooderham, Stephen S. Hecht, Ivonne 4 
M.C.M. Rietjens, Robert L. Smith, Timothy B. Adams, Maria Bastaki, Christie L. Harman, Margaret M. 5 
McGowen, Sean V. Taylor 6 
 7 
Corresponding Author: 8 
Sean V. Taylor, Ph.D. 9 
Scientific Secretary to the FEMA Expert Panel 10 
Flavor and Extract Manufacturers Association 11 
1620 I Street, N.W., Suite 925 12 
Washington, D.C.  20006 13 
Telephone: (202) 293-5800 14 
Facsimile: (202) 463-8998 15 
Email: staylor@vertosolutions.net 16 
 17 
  18 
Page 1 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
2 
Authors Affiliations  19 
 20 
Larry J. Marnett, Ph.D. 21 
Dept. of Biochemistry 22 
Vanderbilt Institute Center in Molecular Toxicology 23 
School of Medicine  24 
Vanderbilt University  25 
Nashville, TN 37232-0146  26 
 27 
Samuel M. Cohen, M.D., Ph.D.  28 
Dept. of Pathology 29 
University of Nebraska Medical Center 30 
983135 Nebraska Medical Center 31 
Omaha, NE  68198-3135  32 
 33 
Shoji Fukushima, M.D., Ph.D.  34 
Japan Bioassay Research Center  35 
2445 Hirasawa, Hadano 36 
Kanagawa 257-0015, Japan  37 
 38 
Nigel J. Gooderham, Ph.D.  39 
Dept. of Surgery and Cancer, 40 
Biomolecular Medicine 41 
Imperial College of Science  42 
Sir Alexander Fleming Building 43 
London SW7 2AZ, United Kingdom 44 
 45 
 46 
Page 2 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
3 
Stephen S. Hecht, Ph.D. 47 
Wallin Professor of Cancer Prevention 48 
Masonic Cancer Center and 49 
Dept. of Laboratory Medicine and Pathology  50 
University of Minnesota 51 
MMC 806 52 
420 Delaware St., S.E. 53 
Minneapolis, MN 55455 54 
 55 
Ivonne M.C.M. Rietjens, Ph.D.  56 
Division of Toxicology  57 
Wageningen University 58 
Tuinlaan 5 59 
6703 HE Wageningen 60 
The Netherlands 61 
 62 
Robert L. Smith, Ph.D. 63 
Molecular Toxicology 64 
Imperial College School of Medicine 65 
18 Guildown Avenue 66 
Woodside Park  67 
London N12 7DQ 68 
United Kingdom 69 
 70 
Timothy B. Adams, Ph.D. 71 
Flavor and Extract Manufacturers Association 72 
1620 I Street, NW Suite 925 73 
Washington, DC 20006 USA 74 
Page 3 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
4 
 75 
Maria Bastaki, Ph.D. 76 
Flavor and Extract Manufacturers Association 77 
1620 I Street, NW Suite 925 78 
Washington, DC 20006 USA 79 
 80 
Christie Lucas Harman, MPH 81 
Flavor and Extract Manufacturers Association 82 
1620 I Street, NW Suite 925 83 
Washington, DC 20006 USA 84 
 85 
Margaret M. McGowen, Ph.D. 86 
Flavor and Extract Manufacturers Association 87 
1620 I Street, NW Suite 925 88 
Washington, DC 20006 USA 89 
 90 
Sean V. Taylor, Ph.D. 91 
Flavor and Extract Manufacturers Association 92 
1620 I Street, NW Suite 925 93 
Washington, DC 20006 USA  94 
  95 
Page 4 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
5 
96 
Page 5 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
6 
Keywords: terpene tertiary alcohols; flavoring ingredients; FEMA GRAS 97 
 98 
 99 
 100 
Abbreviations: ADH = alcohol dehydrogenase; bw = body weight; CES = carboxylesterases; CYP = 101 
cytochrome P; DNA = deoxyribonucleic acid; DT = Decision Tree; F = Female; FEMA = The Flavor and 102 
Extract Manufacturers Association of the United States; GRAS = Generally Recognized as Safe; GRASa = 103 
GRAS affirmed; GRASr = GRAS reaffirmed; ip = intraperitoneal; LD50 = median lethal dose; IC50 = 104 
median inhibitory concentration; JECFA= Joint FAO/WHO Expert Committee on Food Additives; Ki = 105 
inhibition constant; M = Male; MSDI = maximized survey-derived intake; NA = data not available; NAS = 106 
National Academy of Science; NOAEL = No-observed-adverse effect level; NOEL = no-observed-effect 107 
level; NTP = National Toxicology Program; ppm = parts per million; SLR = scientific literature review; 108 
UDS = unscheduled DNA synthesis. 109 
  110 
Page 6 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
7 
Acknowledgment 111 
This work was supported by the Flavor and Extract Manufacturers Association. The Expert Panel of the 112 
Flavor and Extract Manufacturers Association is independent but is financially supported by the Flavor and 113 
Extract Manufacturers Association. The authors declare that there are no conflicts of interest. 114 
 115 
Author Contributions 116 
Marnett, Cohen, Fukushima, Gooderham, Hecht, Rietjens, and Smith interpreted the results and drafted the 117 
manuscript. Adams, Bastaki, Harman, McGowen, and Taylor researched and compiled available study data 118 
and assisted in the drafting of the manuscript.  119 
   120 
Page 7 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
8 
Abstract 121 
This publication is the first in a series of publications by the Expert Panel of the Flavor and 122 
Extract Manufacturers Association (FEMA) summarizing the Panel’s third re-evaluation of GRAS status 123 
referred to as the GRASr2 program.  In 2011, the Panel initiated a comprehensive program to re-evaluate 124 
the safety of more than 2,700 flavor ingredients that have previously met the criteria for GRAS status under 125 
conditions of intended use as flavor ingredients.  Elements that are fundamental to the safety evaluation of 126 
flavor ingredients include exposure, structural analogy, metabolism, pharmacokinetics and toxicology.  127 
Flavor ingredients are evaluated individually and in the context of the available scientific information on 128 
the group of structurally related substances.  Scientific data relevant to the safety evaluation of the use of 129 
aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances as flavoring 130 
ingredients are evaluated. The group of aliphatic acyclic and alicyclic terpenoid tertiary alcohols and 131 
structurally related substances was reaffirmed as GRAS (GRASr2) based, in part, on their rapid absorption, 132 
metabolic detoxication, and excretion in humans and other animals; their low level of flavor use; the wide 133 
margins of safety between the conservative estimates of intake and the no-observed-adverse effect levels 134 
determined from subchronic studies and the lack of significant genotoxic and mutagenic potential.   135 
 136 
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Introduction 138 
For over fifty years, the Expert Panel of the Flavor and Extract Manufacturers Association 139 
(FEMA) has served as the primary, independent body evaluating the safety of flavor ingredients. A key part 140 
of the FEMA GRAS program is the cyclical re-evaluation of the “generally recognized as safe” status of 141 
flavor ingredients determined to be GRAS by the FEMA Expert Panel during the course of its operations. 142 
The Panel has previously completed two re-evaluations of all FEMA GRAS flavor ingredients.  This 143 
summary represents the first in a series of publications summarizing the Expert Panel’s third re-evaluation 144 
of GRAS status referred to as the GRASr2 program. While these summaries contain only critical data 145 
relevant to the safety evaluation, the Expert Panel has reviewed all of the available data during the course 146 
of its safety evaluation. 147 
Currently, the FEMA Expert Panel has determined that over 2,700 flavor ingredients have met the 148 
criteria for GRAS status under conditions of intended use as flavor ingredients.  The FEMA GRAS 149 
program is ongoing; Panel decisions on individual flavor ingredients are provided to the U.S. Food and 150 
Drug Administration and are published on a regular basis on the FEMA website and in Food Technology.  151 
Elements that are fundamental to the safety evaluation of flavor ingredients include exposure, structural 152 
analogy, metabolism, pharmacokinetics and toxicology (Smith and others 2005a). 153 
Flavor ingredients are evaluated individually and in the context of the available scientific 154 
information on the group of structurally related substances.  The group of aliphatic acyclic and alicyclic 155 
terpenoid tertiary alcohols and structurally related substances was reaffirmed as GRAS (GRASr2) based, in 156 
part, on their self-limiting properties as flavoring substances in food; their rapid absorption, metabolic 157 
conversion, and excretion in humans and experimental animals; their low level of flavor use; the wide 158 
margins of safety between the conservative estimates of intake and the no-observed-adverse effect levels 159 
(NOAEL) determined from subchronic and chronic studies and the lack of genotoxic and mutagenic 160 
potential.  This evidence of safety is supported by the fact that the intake of aliphatic acyclic and alicyclic 161 
terpenoid tertiary alcohols and structurally related substances as natural components of traditional foods is 162 
greater than their intake as intentionally added flavoring substances. 163 
 164 
Chemical Identity 165 
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As part of the GRASr2 program, the FEMA Expert Panel (FEXPAN) evaluated a group of 44 166 
flavor ingredients that fit into the group of aliphatic acyclic and alicylic terpenoid tertiary alcohols and 167 
structurally related flavoring ingredients. This group includes 14 aliphatic terpene tertiary alcohols, 8 168 
alicylic terpene alcohols, 6 esters of terpene tertiary alcohols, 3 alicyclic tertiary alcohols and 2 esters of 169 
alicyclic tertiary alcohols, 2 aliphatic tertiary alcohols, 3 phenyl tertiary alcohols and 6 esters of phenyl 170 
substituted aliphatic tertiary alcohols. 171 
FEXPAN previously re-evaluated 23 members of this chemical group and all were determined to 172 
be GRAS reaffirmed (GRASr) under conditions of use presented in 1995. In the intervening time period 173 
there have been substantial increases in the volume of use of some members of this group as flavor 174 
ingredients, as reported in the 2005 FEMA Poundage Update Survey (Gavin and others 2008).  175 
Additionally, 20 new substances have been evaluated and determined to be GRAS. 176 
 177 
Exposure 178 
From the most recent annual poundage surveys, of the 44 substances in this review 7 have 179 
reported volumes of greater than 500 kg/year (see Table 1).  More than 76% of the total annual volume of 180 
production for this group is accounted for by linalool and linalyl acetate (Gavin and others 2008).   The 181 
volumes of production reported for linalool and linalyl acetate are 200% and 166%, respectively, greater 182 
than the annual volumes reported in the 1995 volume of use survey (Lucas and others 1999; Gavin and 183 
others 2008) and 840% and 560%, respectively, greater than the annual volumes evaluated in the original 184 
GRASr of the group (NAS 1989).  Consequently, the estimated daily per capita intakes using maximized 185 
survey-derived intake (MSDI) for these two materials have increased 5- and 15-fold, respectively, as 186 
compared to their original GRASr evaluations. Other substances with high volumes are alpha-terpineol and 187 
its acetate ester, butyrate esters of alpha,alpha-dimethylphenethyl alcohol (see Table 1). 188 
Aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances often 189 
have a sweet floral rose to a fruity citrus green organoleptic profile.  The majority impart a balsamic rose or 190 
bergamot citrus flavor and are used as flavor ingredients at average usual use levels of 1-10 ppm in a wide 191 
range of food categories, but most commonly in baked goods, beverages, candies, chewing gum, frozen 192 
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dairy and gelatins and puddings. The few with specialized flavor profiles, such as cool or minty, are used at 193 
much higher levels, with average maximum use levels in excess of 1000 ppm in chewing gum. 194 
Twenty-two of the 44 flavor ingredients in this group have been reported to occur naturally, and 195 
can be found in chamomile, cocoa, coffee, a variety of fruits and especially citrus fruit varieties and 196 
vegetables, lemon juice, black and green teas, calamus, soybean, pepper, strawberry guava, beer and wine 197 
(TNO 2013). For some substances within this group, quantitative data are available that indicate that their 198 
consumption as naturally occurring constituents of food is far greater than their intake as flavor ingredients 199 
(Stofberg and Grundschober 1987). 200 
Annual volumes of production for each ingredient plus the daily per capita intake values 201 
calculated using MSDI and reported natural occurrence are summarized in Table 1. 202 
 203 
Absorption, Distribution, Metabolism and Elimination 204 
As described in the previous GRAS affirmation and GRASr group summaries, aliphatic acyclic 205 
and alicyclic terpenoids and related esters undergo efficient metabolism.  Based on the results of studies 206 
under a wide variety of conditions, including aqueous buffered media, simulated gastric juice, simulated 207 
human intestinal fluid, blood plasma, whole hepatocytes and liver microsome preparations, terpene esters 208 
formed from tertiary alcohols (e.g., linalool) and simple aliphatic carboxylic acids are expected to undergo 209 
hydrolysis.  Although differences in the rates of hydrolysis occur under in vitro conditions in gastric juice 210 
and intestinal fluids, ready hydrolysis is observed in tissue preparations that have an abundant 211 
concentration of carboxylesterases (CES), especially the liver (Hosokawa 2008; Fukami and Yokoi 2012).  212 
The most important class of these enzymes is the B-esterases, which are members of the serine esterase 213 
superfamily. Generally, CES enzymes are ubiquitous throughout mammalian tissues and are found at the 214 
highest levels in hepatocytes (Hosokawa 2008; Fukami and Yokoi 2012).  CES have been classified into 5 215 
major subgroups based on their catalytic capabilities.  For the present discussion the two subgroups of 216 
interest are CES1 which hydrolyzes esters composed of a large carboxyl group and a small alcohol group, 217 
and CES2 with typical substrates composed of a small carboxyl group and a large alcohol (Fukami and 218 
Yokoi 2012). 219 
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In general, esters are hydrolyzed to their corresponding alcohol and carboxylic acid. It is expected 220 
that the tertiary aromatic alcohols will undergo direct conjugation of the hydroxyl group with glucuronic 221 
acid (Williams 1959), while the tertiary terpenoid alcohols formed as a result of hydrolysis are rapidly 222 
absorbed and converted to the glucuronic acid conjugate in the urine or tracked as expired CO2 (Phillips and 223 
others 1976; Diliberto and others 1988). 224 
Linalyl esters (Nos. 3-10) or those derived from alpha-terpineol (Nos. 12-17) are expected to be 225 
hydrolyzed in humans to yield the parent terpenoid alcohol (linalool or alpha-terpineol, respectively) and 226 
the corresponding saturated aliphatic carboxylic acid.  Methyl 1-acetoxycyclohexyl ketone (No. 23) is 227 
expected to hydrolyze to acetic acid and methyl 1-hydroxycyclohexyl ketone. Similarly it is expected that 228 
esters of alpha,alpha-dimethylphenethyl alcohol (Nos. 31-34, 37 and 38) will be rapidly hydrolyzed to yield 229 
alpha,alpha-dimethylphenethyl alcohol and the corresponding acid. 230 
Linalyl acetate was facilely hydrolyzed in water and simulated gastric and pancreatic fluids in an 231 
in vitro hydrolysis study.  The mean half-lives for linalyl acetate hydrolysis were 5.5 and 52.5 minutes in 232 
gastric and pancreatic fluids, respectively (Hall 1979). In neutral gastric juice, linalyl acetate is slowly 233 
hydrolyzed (t½ = 121 min.) to a mixture of linalool and the ring-closed isomer α-terpineol (see Figure 1). 234 
In simulated gastric juice, linalyl acetate is rapidly hydrolyzed (t½ < 5 min.) to yield linalool, and this 235 
rapidly rearranges into α-terpineol (Hall 1979; Buck and Renwick 1998a).  However, when incubated with 236 
intestinal fluid in the presence and absence of pancreatin, linalyl acetate was slowly hydrolyzed (t½ = 153-237 
198 min) (Buck and Renwick 1998b).  Hydrolysis studies using homogenates of rat intestinal mucosa, 238 
blood, and liver show slower rates of  hydrolysis of linalyl acetate than in acidic gastric juice (rate constant 239 
for hydrolysis k = 0.01 to 0.0055 min
-1
 vs > 5 min
-1
 in gastric juice).  Based on the in vitro hydrolysis data, 240 
it can be concluded that linalyl acetate and other linalyl esters are hydrolyzed in gastric juice to yield 241 
linalool, which undergoes rapid ring-closure to yield α-terpineol.  Both linalool and α-terpineol may then 242 
be either conjugated and excreted or oxidized to more polar excretable metabolites. 243 
In humans and animals, the principle route of elimination for tertiary alcohols is through formation 244 
of glucuronic acid conjugates and excretion in the urine and feces (Williams 1959; Parke and others 1974a, b; 245 
Horning and others 1976; Ventura and others 1985).  Unsaturated terpenoid tertiary alcohols have the 246 
potential to undergo allylic oxidation to form polar diol metabolites which may be excreted either free or 247 
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conjugated.  Those diols containing a primary alcohol function may undergo further oxidation to the 248 
corresponding carboxylic acid (Horning and others 1976; Ventura and others 1985; Madyastha and Srivatsan 249 
1988). 250 
The metabolic fate of the aliphatic tertiary alcohol linalool (No. 1) has been studied in mammals 251 
(Figure 1).  Linalool undergoes rapid oxidation (t½ for linalool = 11 min.) in activated CYP-450 rat liver 252 
homogenate (Buck and Renwick 1998c).  Rats orally administered a single dose of 500 mg/kg bw 
14
C -253 
linalool excreted 55% of the radiolabel in the urine as the glucuronic acid conjugate, while 23% was 254 
excreted as CO2 in expired air, and 15% was excreted in the feces within 72 hours of dose administration.  255 
After 72 hours nearly all of the radiolabel had cleared the body with only 3% of the radioactivity detected 256 
in tissues (Parke and others 1974a).  Reduction metabolites such as dihydro- and tetrahydrolinalool were 257 
also identified in the urine after administration of a single dose of linalool to rats (Rahman 1974) (see 258 
Figure 1). 259 
In a repeat-dose study, male rats (IISc strain) were administered 800 mg/kg bw/day of linalool for 20 260 
days.  A notable increase in allylic oxidation products 8-hydroxylinalool and 8-carboxylinalool was seen in 261 
the urine with an increase in cytochrome P-450 (CYP450) activity in the liver microsomes of 50% after three 262 
days and a return to control values after six days (Chadha and Madyastha 1984).  In a similar study, 500 mg 263 
linalool/kg bw/day administered to Wistar rats for 64 days did not induce CYP450 until the 30
th
 day of 264 
treatment (Parke and others 1974b). 265 
The data suggest that glucuronic acid conjugation and excretion is the primary route of metabolism 266 
of linalool.  Allylic oxidation becomes an important pathway only after repeated dosing.  It has been 267 
suggested that the biotransformation of the diol metabolite of linalool to the corresponding aldehyde via the 268 
action of the NAD
+
-dependent enzyme alcohol dehydrogenase (ADH) is inhibited due to the bulky nature of 269 
the neighboring alkyl substituents and the substrate specificity of the enzyme (Eder and others 1982). 270 
In a repeat-dose study, male albino rats (IISc strain) were administered 600 mg/kg bw/day of alpha-271 
terpineol for 20 days.  Metabolite analysis showed oxidation at the allylic methyl group to the corresponding 272 
carboxylic acid, of which a small fraction was hydrogenated to yield the corresponding saturated carboxylic 273 
acid (Madyastha and Srivatsan 1988) (see Figure 2).  In addition, α-terpineol resulted in a statistically 274 
significant induction of liver microsomal CYP-450 content up to 104% and an increase in the activity of 275 
Page 13 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
14
NADPH-cytochrome c reductase in treated rats (Madyastha and Srivatsan 1988), suggesting that oxidation is 276 
mediated by CYP-450. 277 
In a minor pathway, epoxidation of the alkene of α-terpineol is followed by hydrolysis to a triol 278 
metabolite, 1,2,8-trihydroxy-p-menthane, which also has been reported in humans following ingestion of a 279 
pine oil disinfectant containing α-terpineol (Horning and others 1976).  It is expected that alpha-terpineol 280 
would undergo metabolism like linalool (Chadha and Madyastha 1984), primarily by glucuronic acid 281 
conjugation and excretion in the urine. 282 
Bicyclic tertiary alcohols (Nos. 21, 22, 39, 41 and 42) are relatively stable in vivo, but are 283 
eventually conjugated with glucuronic acid and excreted (Williams 1959).  In rabbits the structurally 284 
related bicyclic tertiary alcohol β-santenol (2,3,7-trimethyl bicyclo[2.2.1]-heptan-2-ol) was conjugated with 285 
glucuronic acid (Williams 1959). 286 
In a metabolism study using the structurally related terpenoid tertiary alcohol trans-sobrerol in 287 
humans, dogs, and rats, ten metabolites were isolated in urine, eight of which were also detected in urine 288 
from humans exposed to trans-sobrerol.  In this study, the two principle modes of metabolism observed 289 
were allylic oxidation of the ring positions and alkyl substituents, and conjugation of the tertiary alcohol 290 
functions with glucuronic acid.  These are common pathways converting tertiary (Ventura and others 1985) 291 
and secondary (Yamaguchi and others 1994) terpenoid alcohols to polar metabolites that are easily excreted 292 
in the urine and feces (see Figure 3). 293 
Potential pharmacokinetic outcomes in mammalian plasma were analyzed upon intravenous 294 
administration of sclareol (No. 41) at 100 mg/kg bw to two male Wistar rats.  Plasma samples were 295 
collected at 5, 15, 30, 60, 180, 360 minutes, 12 and 24 hours post-administration.  At 5 minutes post-296 
injection, plasma levels of sclareol were 84.9 µg/mL.  The sclareol plasma concentration dropped to 42.9 297 
µg/mL after 180 minutes and sclareol was not detectable at 360 minutes.  The data indicate a rapid biphasic 298 
disappearance of sclareol from plasma following intravenous dosing.  The authors suggest that sclareol may 299 
be distributed in fatty tissue due to its high lipophilicity (Kouzi and others 1993). 300 
In a second study, sclareol was administered to 2 male Wistar rats by intravenous injection at 100 301 
mg/kg bw, and to male Wistar rats by intragastric instillation at 1000 mg/kg bw.  Urine and fecal samples 302 
were collected from all rats at periodic intervals over 144 or 72 hours, respectively.  Bile samples were 303 
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collected only from rats given intravenous injections at periodic intervals over 30 hours.  No sclareol was 304 
detected in urine, either untreated or treated with beta-glucuronidase, at any time.  No sclareol was detected 305 
in fecal samples from rats treated via intravenous injection, but 9% of the initial dose was found in fecal 306 
samples of rats orally administered sclareol.  The bile samples from rats receiving sclareol by intravenous 307 
injection showed very low levels (0.02%) of unchanged sclareol over a 3-hour period.  Very low levels 308 
(0.04%) of oxidized metabolites were found in bile after 3 hours, including 3-alpha-hydroxysclareol 309 
(0.24%), 3-beta-hydroxysclareol (0.075%), 18-hydroxysclareol (0.056%), and 3-ketosclareol (0.03%). 310 
Sclareol or its oxidized metabolites were not observed in bile samples collected at any other time during the 311 
30-hour study.  The authors hypothesized that the low sensitivity of the assay technique may have 312 
prevented detection of low levels of sclareol and its metabolites over the course of the study.  While only a 313 
very small percentage of intravenously-injected sclareol (<0.05%) could be accounted for in these 314 
experiments, the authors suggested that other mammalian metabolites were formed that were not detected 315 
in the assays used (Kouzi and others 1993). 316 
In order to determine the phase I metabolism of cedrol (No. 42), Bang and Ourrison (1975) and 317 
Trifilieff and others (1975) administered cedrol to rabbits and dogs, respectively.  In rabbits, only 318 
metabolites formed by hydroxylation at C3 were identified, and the two resulting epimers, alpha-319 
epiisobiotol and alpha-isobiotol, were subsequently dehydrated at C7/C8.  The metabolic fate in dogs was 320 
far less regioselective and metabolites that were identified were products of oxidation at multiple locations 321 
on the ring as well as at methyl groups.  While the species-specific biotransformation outcomes are 322 
significant, for humans it is most relevant to recognize that the initial glucuronidation at the hydroxyl 323 
moiety of cedrol is inefficient because of steric hindrance, and as a result additional functionalization prior 324 
to conjugation must occur.  In the case of cedrol, the hydroxylation of a non-activated saturated carbon 325 
atom is the most likely pathway (Bang and Ourisson 1975; Trifilieff and others 1975; Ishida 2005). 326 
Terpenoids are also recognized for their ability to alter the activity of various drug-metabolizing 327 
hepatic enzymes (Parke and Rahman 1969).  The inhibitory effect of chamomile essential oil and its major 328 
constituents (e.g., alpha-bisabolol, No. 43) was studied on four selected human cytochrome P450 enzymes 329 
(CYP1A2, CYP2C9, CYP2D6 and CYP3A4).  Increasing concentrations of the test compounds were 330 
incubated with individual, recombinant CYP isoforms and their effect on the conversion of surrogate 331 
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substances was measured fluorometrically; enzyme inhibition was expressed as IC50 and Ki values in 332 
relation to positive controls. alpha-Bisabolol (IC50 = 2.18 µM) produced a significant inhibition of 333 
CYP2C9 and CYP2D6.  As indicated by these in vitro data, chamomile preparations contain constituents 334 
that can inhibit the activities of major human drug metabolizing enzymes; interactions with drugs whose 335 
route of elimination is mainly through CYP oxidation (especially CYP1A2) are therefore possible (Ganzera 336 
and others 2006). 337 
Studies in humans, dogs, rabbits and rats have shown that aliphatic acyclic and alicyclic terpenoid 338 
tertiary alcohols are absorbed to a small or large extent depending upon lipophilicity and are distributed 339 
primarily to adipose tissue.  Oxidation to polar metabolites and/or conjugation with glucuronic acid, 340 
followed by excretion in the urine is expected for all of the flavoring ingredients in this group. Small 341 
amounts may be expired in exhaled air.  The esters within this group (Nos. 3-10, 12-17, 23, 32-36, 38 and 342 
39) are expected to be hydrolyzed in humans to their component tertiary alcohols and acids.  The available 343 
data demonstrate that the aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related 344 
substances are rapidly absorbed, distributed, metabolized and excreted. 345 
 346 
Toxicology 347 
(a) Acute toxicity 348 
Oral LD50 values have been reported for 24 of the 43 substances in this group (Jenner and others 349 
1964; Colaianni 1967; Moreno 1971, 1973, 1975, 1976, 1977, 1982; Russell 1973; Levenstein 1975; 350 
Griffiths 1979; Moore 2000; Piccirillo and Hartman 1980; Yamahara and others 1985; Collinson 1989; 351 
Rhone-Poulenc 1992).  LD50 values range from 1,300 to greater than 36,300 mg/kg bw, demonstrating that 352 
the oral acute toxicity of tertiary alcohols and related esters is extremely low. 353 
 354 
(b) Short-term studies of toxicity 355 
The results of short-term studies with representative acyclic and alicyclic tertiary terpenoid 356 
alcohols and related substances are summarized in Table 2 and key studies are described below. 357 
A mixture of linalool (No 1.) and citronellol (1:1) resulting in average daily intake of 50 mg/kg bw 358 
each, and a mixture of linalyl acetate (No 4), linalyl isobutyrate (No 7) and geranyl acetate at levels 359 
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calculated to result in average daily intakes of 24, 27, or 48 mg/kg bw, respectively were incorporated into 360 
the feed of male and female rats (number and strain not specified) for 12 weeks. A slight retardation of 361 
body weight gain was observed only in males fed the linalool mixture and in females fed the linalyl esters 362 
mixture.  However, these effects were concluded by the authors to be biologically insignificant (Oser 363 
1967). 364 
Four groups of 10 male and 10 female Osbourne-Mendel rats were fed the structurally related 365 
ester of linalool, linalyl cinnamate, at dietary concentrations of up to 10,000 ppm for 17 weeks, which is 366 
estimated to provide a daily intake of up to 500 mg/kg bw/day.  There were no differences between treated 367 
and control animals in the parameters evaluated (Hagan and others 1967). 368 
Similarly, groups of ten (10) male and 10 female weanling Osborne-Mendel rats were fed terpinyl 369 
acetate (No. 13) in the diet for 20 weeks at concentrations of 0, 1000, 2500 or 10,000 ppm, calculated to 370 
result in daily intakes of 0, 50, 125 and 500 mg/kg bw/d, respectively.  All animals were examined for 371 
growth, hematology, and macroscopic and microscopic changes in the tissues.   No statistically significant 372 
adverse effects were reported at any dose level (Hagan and others 1967).    373 
In the same study, groups of 5 weanling Osborne-Mendel rats per sex were housed individually in 374 
wire cages and administered 0 or 10,000 ppm of alpha,alpha-dimethylphenethyl alcohol (No. 30) in the 375 
diet (approximately 1,000 mg/kg bw/day) for 16 weeks.  In addition, groups of 10 rats per sex were 376 
administered 0 or 1,000 ppm of alpha,alpha-dimethylphenethyl alcohol in the diet (approximately 100 377 
mg/kg bw/day) for 28 weeks.  No effects were observed due to the administration of the test material at 378 
either dose level (Hagan and others 1967). 379 
Groups of Sprague-Dawley rats (5/sex) were maintained on diets containing 2,3,4-trimethyl-3-380 
pentanol (No. 24) at a dose level of 0 or 10 mg/kg bw/day for 14 days.  Test and control groups showed no 381 
significant differences in relative or absolute kidney and liver weights (Madarasz 1997). 382 
During its fifty-first meeting, the Joint FAO/WHO Expert Committee on Food Additives 383 
concluded that methyl 1-acetoxycyclohexylketone (No. 23) was not supported by a relevant No Observed 384 
Effect Level (NOEL) (JECFA 2000). Data on the structurally related substance, 6-385 
acetoxydihydrotheaspirane (No. 35) in a 90-day study in rats (Griffiths 1979), provides a NOAEL of 3 386 
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mg/kg bw/day which is at least 100,000 times the daily per capita intake of methyl 1-acetoxycyclohexyl 387 
ketone when used as a flavor ingredient. 388 
In studies using groups of 16 Sprague-Dawley rats per sex per dose, 6-acetoxydihydrotheaspirane 389 
(No. 35) and 6-hydroxydihydrotheaspirane (No. 36) were administered by gavage at doses of 3 mg/kg 390 
bw/day (Griffiths 1979) and 0.154 mg/kg bw/day, respectively (Griffiths 1976) for 91 days. No treatment-391 
related clinical effects were observed in either study.  In the acetoxydihydrotheaspirane study, treated 392 
females were reported to have significantly decreased body weights compared to controls at week 13.  In 393 
comparison to controls, a significant increase in relative spleen weight was observed in treated males.  394 
Significant reductions in hemoglobin, hematocrit, and red blood cell count were observed in treated 395 
females at the end of the study relative to levels observed in controls. In the 6-hydroxydihydrotheaspirane 396 
study, one male death that occurred within 1 hour of dosing and necropsy revealed oil in the lungs and 397 
trachea but not in the upper part of the gastro-intestinal tract, indicating a gavage error.  At week 12, treated 398 
males had significantly greater hemoglobin concentrations relative to controls.  At week 6, but not at week 399 
12, treated males and females had significantly greater total leukocyte counts compared to the controls 400 
(Griffiths 1976).  These hematological changes were considered variations and not adverse effects because 401 
of the lack of reproducibility between sexes or a later time point, respectively. No other statistically 402 
significant adverse effects were reported (Griffiths 1976, 1979). 403 
In a 28-day oral toxicity study, Sprague-Dawley rats (10/sex/ingredient) approximately 1 month of 404 
age, were administered 10 mg/kg bw/day of sclareol (98.3% pure, No. 41) or 10 mg/kg bw/day of cedrol 405 
(97% pure, No. 42) by intragastric instillation in carboxymethylcellulose ith the control group receiving 406 
vehicle only.  It was determined that the actual dose achieved was 8.8 mg/kg bw/day of sclareol and 8.4 407 
mg/kg bw/day of cedrol.  In rats dosed with sclareol, statistically significant increases in mean absolute and 408 
relative liver weight in males and liver to brain weight ratio in females were found not to correlate with 409 
evidence of macro- or microscopic alterations or associated enzyme activity.  Minor clinical pathology and 410 
histopathological alterations were considered incidental, and therefore toxicologically non-adverse, 411 
according to the authors.  Other statistically significant organ weight changes were isolated and not 412 
consistent between the sexes, and were therefore, considered not to be related to administration of the test 413 
substance (Merkel 2006). 414 
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Groups of 40 (strain not specified) rats (20/sex/dose) or Beagle dogs (3/sex/dose) were 415 
administered alpha-bisabolol (No. 43) by intragastric instillation at 0, 2.0 or 3.0 ml/kg bw/day for 4 weeks.  416 
These dose levels correspond to calculated daily intakes of 0, 1,860 or 2,790 mg/kg bw/day.  In the rats, 417 
slight motor agitation and decreased body weight gain were noted in animals of both dose groups and the 418 
mortality rate was 20% in the 2,790 mg/kg bw/day group.  Decreased body weight gain was noted.  Post-419 
mortem findings in the 2,790 mg/kg bw/day group included inflammatory changes in the liver, trachea, 420 
spleen, thymus, and stomach (Habersang and others 1979).  In the Beagle dog study, the high dose was 421 
increased to 3,720 mg/kg bw/day after 2 weeks.  A loss of appetite, reduced feed intake, and vomiting were 422 
observed in two of the six dogs receiving 1,860 mg/kg bw/day.  At necropsy it was noted that the liver 423 
weight relative to the body weight was increased.  Reactions and observations were more severe in the high 424 
dose group.  No other changes were noted as compared to controls (Habersang and others 1979). 425 
 426 
(c) Developmental toxicity studies 427 
Linalool was studied for potential developmental toxicity in rats.  Four groups of presumed 428 
pregnant female Sprague-Dawley rats (25/group) were administered 0 (vehicle), 250, 500, or 1,000 mg 429 
linalool/kg bw/day by intragastric instillation in corn oil on gestational days 7-17.  There were no clinical 430 
signs of toxicity.  No deaths related to the administration of linalool occurred.  One dam in the low dose 431 
delivered early on the day of scheduled sacrifice.  This delivery was considered unrelated to administration 432 
of linalool because the observation was not dose-dependent.  There were no macroscopic lesions at 433 
necropsy in this dam and her litter consisted of 12 live delivered pups and one early in utero resorption.  All 434 
pups appeared normal for this dam and no external, soft tissue or skeletal alterations occurred in these pups.  435 
Body weight gains were reduced by 11% in the 1,000 mg/kg bw per day dose group during the dosing 436 
period (in comparison with control) and this was accompanied by absolute and relative feed consumption 437 
values that were reduced and significantly reduced (by 7%) in the 1,000 mg/kg bw/day dose group for the 438 
entire test period in comparison to the control group.  The lower dose groups showed no difference in body 439 
weight gain or feed consumption when compared to controls.  No Caesarean-section or litter parameters 440 
were affected by dosages of linalool as high as 1,000 mg/kg bw per day.  The litter averages for corpora 441 
lutea, implantations, litter sizes, live fetuses, early and late resorptions, percent resorbed conceptuses, 442 
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percent live male fetuses and fetal body weights were similar across all test groups.  No dam had a litter 443 
that consisted of all resorbed conceptuses.  All placentas appeared normal.  No macroscopic external, soft 444 
tissue or skeletal alterations appeared to be caused by dosages of linalool as high as 1,000 mg/kg bw per 445 
day.  There were no dose-dependent or significant differences in the litter or fetal incidences of any 446 
macroscopic external, soft tissues or skeletal alterations.  All ossification averages were comparable to 447 
vehicle control group values and did not significantly differ among the groups. 448 
Based on these data, the maternal NOAEL of linalool is 500 mg/kg bw/day.  The 1,000 mg/kg 449 
bw/day dose caused non-significant reductions in body weight gain and also reduced absolute and relative 450 
feed consumption values during the dosage period.  However, following the completion of the dosing 451 
period, these effects were reversed.  The developmental NOAEL is at least 1,000 mg/kg bw/day, since no 452 
embryo-fetal effects were observed at the highest dose tested (Lewis 2006). 453 
A study was conducted in Sprague-Dawley and Wistar rats and in New Zealand white rabbits to 454 
determine the potential developmental toxicity of alpha-bisabolol (No. 43).  In two separate experiments, 455 
groups of presumed pregnant rats or presumed pregnant rabbits were administered 0, 0.25, 0.50 or 1.0 456 
ml/kg in the first experiment, and 3.0 ml/kg bw/day of alpha-bisabolol in the second, by intragastric 457 
instillation on days 6-15 of pregnancy for rats and days 6-18 for rabbits.  These dose levels correspond to 458 
calculated daily intakes of 0, 233, 466, 931 and 2,793 mg/kg bw/day.  At the highest dose of the test 459 
substance administered, there were reduced numbers of live fetuses in addition to reduced fetal weights and 460 
increased numbers of resorptions in both rats and rabbits.  No adverse effects were observed in any other 461 
dose group.  The NOAEL for reproductive effects in Sprague-Dawley and Wistar rats or New Zealand 462 
white rabbits is 931 mg/kg bw/day (Habersang and others 1979). 463 
 464 
(d) Genotoxicity 465 
Genotoxicity testing has been performed on substances in this group.  The results of these tests are 466 
summarized in Table 3 and are described below. 467 
 468 
In vitro 469 
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No increase in reverse mutations were observed in Ames assays in Salmonella typhimurium strains 470 
TA98, TA100, TA102, TA1535, TA1537, TA1538, TA97a, TA92, and TA94 and Escherichia coli WP2 471 
uvrA for linalool (No. 1), linalyl acetate (No. 4), linalyl propionate (No. 5), alpha-terpineol (No 11), p-472 
menth-8-en-1-ol (beta-terpineol (No. 20), 1-phenyl-3-methyl-3-pentanol (No. 27), cedrol (No. 42), 473 
alpha,alpha-dimethylphenethyl formate (No. 31), and alpha-bisabolol (No. 43) at concentrations up to 474 
5,000 µg/plate in the presence and absence of bioactivation systems (Rockwell and Raw 1979; Eder and 475 
others 1980; Florin and others 1980; Wild and others 1983; Ishidate and others 1984; Yoo 1986; Asquith 476 
1989; Heck and others 1989; Scheerbaum 2001; King 2002; Sokolowski 2004; Gomes-Carneiro and others 477 
2005).  These results are summarized in detail in Table 3. 478 
When incubated with Bacillus subtilis H17(rec
+
) and M45 (rec
-
), linalool, linalyl acetate and 479 
terpinyl acetate were negative in the “rec assay” at 17 µg, 18 µg and 19 µg, respectively (Oda and others 480 
1978), but linalool was positive at 10 µl/disk, corresponding to 8,620 µg (56 µmol) (Yoo 1986).  The 481 
positive rec assay results reported by Yoo were most likely due to cytotoxicity to Bacillus subtilis rather 482 
than genotoxicity, given the high concentration. 483 
In a mouse lymphoma assay, linalool was negative in L5178Y TK+/- cells with S-9 metabolic 484 
activation at 200 nl/ml, but weakly positive without S-9 activation at 150 nl/ml (Heck and others 1989).  The 485 
authors of this study noted that the forward mutation assay was not run under conditions controlling for 486 
changes in osmolality and they interpreted the weak positive result not as evidence of genotoxicity but rather 487 
related to cytotoxicity (Heck and others 1989). Negative results were obtained in this assay when cells were 488 
treated with 250 nl/ml or 300 nl/ml of alpha-terpineol, with and without S-9 metabolic activation, respectively 489 
(Heck and others 1989). 490 
Linalool did not induce chromosomal aberrations when incubated with Chinese hamster fibroblast 491 
cells at a maximum concentration of 250 µg/ml (Ishidate and others 1984), nor did it induce unscheduled 492 
DNA synthesis (UDS) in rat hepatocytes at concentrations up to 50 nl/ml (equivalent to 43.1 µg/ml) (Heck 493 
and others 1989).  No chromosomal aberrations were observed when 0, 10, 33, 56, 100, 130 or 180 µg/ml of 494 
linalyl acetate (No. 4) were incubated with human peripheral lymphocytes for 3 hours with 24 and 48-hour 495 
fixation times, with and without metabolic activation (Bertens 2000). Linalyl acetate did not induce UDS in 496 
Fischer or SD rat hepatocytes at concentrations up to 300 nl/ml (Heck and others 1989).  497 
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 498 
In vivo 499 
The potential of 1-phenyl-3-methyl-3-pentanol (No. 27) to induce sex-linked recessive lethal 500 
mutations in adult Drosophila melanogaster was studied in the Basc test.  Mutation frequency was 501 
unaffected when flies were exposed to a 0 or 20 mM (3,565 µg/ml) solution of 1-phenyl-3-methyl-3-502 
pentanol for 3 days (Wild and others 1983). 503 
In a mutagenicity study, 24-hour urine of Sprague-Dawley rats administered 0.5 ml of linalool or 504 
beta-terpineol was incubated with Salmonella typhimurium strains TA98 and TA100 (Rockwell and Raw 505 
1979).  The following samples were tested: undiluted linalool and alpha-terpineol (with metabolic 506 
activation), aliquots of 24-hour urine from rats fed linalool and beta-terpineol (with and without metabolic 507 
activation), aliquots of the ether extract of 24-hour urine (with and without metabolic activation), and 508 
aliquots of the aqueous phase of 24-hour urine ether extract (with and without metabolic activation).  A 509 
range of volumes was tested for each type of sample. Urines were diluted to 60 ml and incubated in the 510 
presence of chloroform and beta-glucuronidase prior to ether extraction.  All tests were negative except for 511 
the ether extract of urine from alpha-terpineol-treated rats. 512 
Linalool (No. 1) was tested for in vivo mutagenicity in the bone marrow micronucleus assay in 513 
Swiss CD-1 mice. Four groups (5/sex/group) received a single dose of the test substance by intragastric 514 
instillation in corn oil; two of these groups were administered 1,500 mg/kg bw of linalool and one group 515 
each was administered 500 or 1,000 mg/kg bw of linalool.  Vehicle controls received corn oil and positive 516 
controls received cyclophosphamide.  Systemic toxicity signs were recorded at least once a day.  The 517 
animals were terminated at 24 or 48 hours after dosing, both femurs were removed, and bone marrow 518 
smears were prepared and analyzed for micronuclei.  The animals of the groups dosed with linalool showed 519 
no decrease in the ratio of polychromatic to normochromatic erythrocytes, which reflects a lack of toxic 520 
effects of this compound on erythropoiesis.  No increase in the frequency of micronucleated polychromatic 521 
erythrocytes was found in the linalool-dosed animals compared to the vehicle controls, whereas 522 
cyclophosphamide produced an increase.  Therefore, linalool was not mutagenic in the micronucleus test 523 
under the experimental conditions used (Meerts 2001). 524 
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In a micronucleus test, groups of 4 male and female NMRI mice (number/sex not reported), 525 
administered single ip doses of 0, 357, 624, 891, or 1,416 mg 1-phenyl-3-methyl-3-pentanol (No. 27)/kg 526 
bw, demonstrated no increase in micronucleated erythrocytes in bone marrow samples obtained 30 hours 527 
post-administration (Wild and others 1983). 528 
 529 
Conclusion for genotoxicity 530 
The testing of these representative materials in vitro in bacterial test systems (Ames assay) and in 531 
vivo in mammalian test systems (micronucleus assay) showed no evidence of mutagenic or genotoxic 532 
potential.  These results are further supported by the lack of positive findings in the Basc test in Drosophila 533 
melanogaster.  The two positive results reported in the literature are questionable at best and most likely 534 
attributable to cytotoxic mechanisms rather than genotoxic mechanisms.  The Bacillus subtilis “rec Assay” 535 
has since been superseded by the OECD-validated Salmonella typhimurium/Escherichia coli reverse 536 
mutation assay in the modern genotoxicity testing battery. 537 
 538 
Conclusion 539 
The group of aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related 540 
substances discussed here was determined to be generally recognized as safe (GRAS) under conditions of 541 
intended use as flavor ingredients by the FEMA Expert Panel in 1965 and several times thereafter (Hall and 542 
Oser 1965, 1970; Oser and Ford 1974, 1978; Oser and others 1984; Newberne and others 1998; Smith and 543 
others 2005b, 2009; Waddell and others 2007).  In 1978, the Panel evaluated the available data and 544 
affirmed the GRAS status of these flavor ingredients (GRASa).  In 1993, the Panel initiated a 545 
comprehensive program to reevaluate the status of all FEMA GRAS flavor ingredients concurrent with a 546 
systematic revision of the FEMA Scientific Literature Reviews (SLRs) and the Panel reaffirmed the status 547 
of this group in 1995 with GRASr status.  In 2012, this group was again reaffirmed as GRAS (GRASr2) 548 
based on knowledge concerning their rapid absorption, metabolic conversion, and excretion in humans and 549 
animals; their low levels of use as flavors in food; the wide margins of safety between the conservative 550 
estimates of intake and the NOAEL or NOEL determined from subchronic studies and the lack of 551 
significant genotoxic and mutagenic potential.  The consistency of the results obtained from subchronic 552 
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studies in rodent models support the conclusion that consumption of aliphatic acyclic and alicyclic 553 
terpenoid tertiary alcohols and structurally related substances as part of the food supply is not associated 554 
with any significant risk to human health. 555 
556 
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Table 1. Identity and exposure data for aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances used as flavoring 743 
ingredients. 744 
 745 
Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
1. Linalool 
2635 I 
78-70-6 
OH
 
49,000 5,413 90 71,619 1 
                                                 
a From  NAS 1989; Lucas and others 1999; Gavin and others 2008. Values greater than zero but less than 0.1 kg were reported as 0.1 kg. 
b MSDI (µg/person per day) calculated as follows: 
 [[(annual volume, kg) x (1 x 109 µg/kg)]/[population x survey correction factor x 365 days]], where population  
(10%, “eaters only") =  31 x 106 for the USA, where the correction factor = 0.8 for the Gavin and others 2008, and Lucas and others 1999  and 0.6 for NAS 1989 and anticipated 
volumes, representing the assumption that only 80% or 60% of the annual flavour volume, respectively, was reported in the poundage surveys (Lucas and others 1999; Gavin and 
others 2008; NAS 1989; private communication to FEMA).  [(µg/person per day)/body weight], where body weight = 60 kg.  Slight variations may occur from rounding.  
c Quantitative data for the United States reported by Stofberg and Grundschober (1987). 
d The consumption ratio is calculated as follows: 
  (annual consumption via food, kg)/(most recent reported volume as a flavouring substance, kg) 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
2. Tetrahydrolinalool 
3060 I 
78-69-3 
OH
 
0.4 0.04 0.001 -
e
 NA 
3. Linalyl formate 
2642 I 
115-99-1 
O
OH
 
24 3 0.04 + NA 
4. Linalyl acetate 
2636 I 
115-95-7 
O
O
 
21,900 2,419 40 18,567 1 
                                                 
e NA, not available; ND, no intake data reported; +, reported to occur naturally in foods (TNO 2013), but no quantitative data; -, not reported to occur naturally in foods 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
5. Linalyl propionate 
2645 I 
144-39-8 
O
O
 
100 11 0.2 + NA 
6. Linalyl butyrate 
2639 I 
78-36-4 
O
O
 
5 1 0.01 + NA 
7. Linalyl isobutyrate 
2640 I 
78-35-3 
O
O
 
73 8 0.1 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
8. Linalyl isovalerate 
2646 I 
1118-27-0 
O
O
 
13 1 0.02 - NA 
9. Linalyl hexanoate 
2643 I 
7779-23-9 
O
O
 
4 0.4 0.007 - NA 
10. Linalyl octanoate 
2644 I 
10024-64-3 
O
O
 
0.5 0.06 0.0009 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
11. alpha-Terpineol 
3045 I 
98-55-5 
OH
 
6,300 696 12 21,451 3 
12. Terpinyl formate 
3052 I 
2153-26-6 
O
H
O
 
0.1 0.01 0.0002 + NA 
13. Terpinyl acetate 
3047 I 
8007-38-0 
O
O
 
82 9 0.2 61 1 
14. Terpinyl propionate 
3053 I 
80-27-3 
O
O
 
30 3 0.06 + NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
15. Terpinyl butyrate 
3049 I 
2153-28-8 
O
O
 
5 0.6 0.009 - NA 
16. Terpinyl isobutyrate 
3050 I 
7774-65-4 
O
O
 
5 0.5 0.008 - NA 
17. Terpinyl isovalerate 
3054 I 
1142-85-4 
O
O
 
5 0.7 0.01 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
18. p-Menth-3-en-1-ol 
3563 I 
586-82-3 
OH
 
2 0.3 0.005 3 2 
19. 4-Carvomenthenol 
2248 I 
562-74-3 
OH
 
640 71 1 38,968 61 
20. p-Menth-8-en-1-ol  (beta-
Terpineol) 
3564 I 
138-87-4 
OH
 
320 47 0.8 1,792 6 
Page 38 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
39
Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
21. 2-Ethyl-1,3,3-trimethyl-2-
norbornanol 
3491 II 
18368-91-7 
OH
 
0.1 0.01 0.0002 - NA 
22. 4-Thujanol 
3239 I 
546-79-2 
OH
 
34 4 0.06 9,200 271 
23. Methyl 1-acetoxycyclohexyl 
ketone
f
 3701 I 
52789-73-8 
11 2 0.03 - NA 
                                                 
f At the fifty-first meeting of the Joint FAO/WHO Expert Committee on Food Additives, methyl 1-acetoxycyclohexylketone (No. 23) was not supported by a relevant NOAEL. 
Data for structurally related substance, 6-acetoxydihydrotheaspirane (No. 35) provided a NOAEL of 3 mg/kg bw/day in a 90-day study in rats (Griffiths 1979) which is at least 
100,000 times the daily per capita intake of  methyl 1-acetoxycyclohexyl ketone when used as a flavor ingredient 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
O
O
O
 
24. 2,3,4-Trimethyl-3-pentanol 
3903 I 
3054-92-0 
OH
 
5 0.7 0.01 - NA 
25. (+/-)-2,4,8-Trimethyl-7-
nonen-2-ol 4212 I 
437770-28-0 
OH
 
1 0.1 0.002 - NA 
26. (E)- and (Z)-2,4,8-Trimethyl-
3,7-nonadien-2-ol 4211 I 
479547-57-4 
OH
 
1 0.1 0.002 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
27. Nerolidol  
2772 I 
7212-44-4 
OH
 
181 20 0.3 300,000 1,657 
28. 1-Phenyl-3-methyl-3-pentanol 
2883 I 
10415-87-9 
OH
 
1 0.1 0.002 - NA 
29. p-alpha,alpha-
Trimethylbenzyl alcohol 3242 I 
1197-01-9 
OH
 
0.1 0.01 0.0002 500,000 5,000,000 
30. (±)-Ethyl 2-hydroxy-2-
methylbutyrate 4268 I 
77-70-3 
O
O
OH
 
50 7 0.117 + NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
31. alpha,alpha-
Dimethylphenethyl alcohol 2393 I 
100-86-7 
OH
 
95 10 0.2 + NA 
32. alpha,alpha-
Dimethylphenethyl formate 
2395 I 
10058-43-2 
O
H
O
 
3 0.4 0.01 - NA 
33. alpha,alpha-
Dimethylphenethyl acetate 
2392 I 
151-05-3 
O
O
 
4,700 519 9 - NA 
34. alpha,alpha-
Dimethylphenethyl butyrate 
2394 I 
10094-34-5 
8,300 917 15 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
O
O
 
35. alpha,alpha-Dimethylbenzyl 
isobutyrate 
2388 I 
7774-60-9 
O
O
 
0.4 0.04 0.0007 - NA 
36. 6-Acetoxydihydrotheaspirane 
3651 II 
57893-27-3 
O
O
O
 
5 0.7 0.0117 - NA 
Page 43 of 58
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of Food Science
For Peer Review
DRAFT 
 
44
Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
37. 6-Hydroxydihydrotheaspirane 
3549 II 
65620-50-0 
O
OH
 
0.4 0.04 0.0007 - NA 
38. Dimethylbenzyl carbinyl 
crotonate 
4403 I 
93762-34-6 
O
O
 
1 0.1 0.002 - NA 
39. Dimethylbenzyl carbinyl 
hexanoate 
4404 I 
891781-90-1 
O
O
 
0.2 0.03 0.0005 - NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
40. Caryophyllene alcohol 4410 I 
56747-96-7 
OH 
5 0.7 0.0117 + NA 
41. Cubebol 4497 I 
23445-02-5 
OH
 
50 7 0.117 + NA 
42. (-)-Sclareol 4502 I 
515-03-7 
OH
OH
 
39 6 0.1 + NA 
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Flavoring Ingredient FEMA 
No. 
DT 
Class 
CAS No. and Structure Most 
Recent 
annual 
volume
a
, 
kg 
Daily per capita 
Intake
b
                       
("eaters only") 
Annual 
volume in 
naturally 
occurring 
foods
c
, kg 
Consumption 
Ratio
d
 
µg/d 
µg/kg 
bw/d 
43. (+)-Cedrol 4503 I 
77-53-2 
OH
 
10 2 0.03 + NA 
44. alpha-Bisabolol 4666 I 
23089-26-1 
OH
 
227 33 0.55 + NA 
 746 
  747 
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Table 2. Short-term toxicity studies on aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances 748 
                                                 
a M=Male; F=Female 
b Total number of test groups does not include control animals. Total number per test group includes both male and female animals.  
c Not specified. 
d Administered with citronellol as part of a 1:1 mixture. 
e The study was performed at a single dose level or multiple dose levels that produced no adverse effects and, therefore, a NOAEL was not determined.  The NOAEL is probably higher than 
the dose level reported here which is the highest dose level that produced no adverse effects. 
f Refers to maternal NOAEL derived from a developmental study  
g Administered with linalyl isobutyrate and geranyl acetate as part of a mixture. 
h Administered with linalyl acetate and geranyl acetate as part of a mixture. 
Flavor ingredient Species, 
Sex
a
 
No. Test 
groups/No. 
per Test 
group
b
 
Route Duration 
(days) 
NOAEL 
(mg/kg 
bw/d) 
Margin of 
Safety 
Reference 
1.  Linalool Rat; M,F 1/--
c
 Diet
d
 84 50d
,e
 >500 (Oser 1967) 
1. Linalool Rat, F 3/25 Gavage 11 500
f
 >5,000 (Lewis 2006) 
4. Linalyl acetate Rat; M,F 1/--c Diet
g
 84 24e 600 (Oser 1967) 
7. Linalyl isobutyrate Rat; M,F 1/--c Diet
h
 84 27e 270,000 (Oser 1967) 
13. Terpinyl acetate Rat; M,F 3/20 Diet 140 500e 2,500,000 (Hagan and others 1967) 
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i Based on a dietary concentration of 10,000 ppm, which is equivalent to 1,000 mg/kg bw. 
j Based on a dietary concentration of 1,000 ppm, which is equivalent to 100 mg/kg bw. 
k Adverse effects seen in lowest dosage group; therefore, this is not a true NOAEL 
l Compared to controls, a significant increase was observed in relative liver weights in males; however, this organ weight variation was not accompanied by any histopathological 
abnormalities or any other adverse effects. 
24. 2,3,4-Trimethyl-3-pentanol Rat; M,F 1/10 Diet 14 10e 1,000,000 (Madarasz 1997) 
30. alpha,alpha-
Dimethylphenethyl alcohol  
Rat; M,F 1/10 Diet 112 1,000c
,i
 5,000,000 (Hagan and others 1967) 
30. alpha,alpha-
Dimethylphenethyl alcohol 
Rat; M,F 1/20 Diet 196 100c
,j 500,000 (Hagan and others 1967) 
35. 6-Acetoxydihydrotheaspirane Rat; M,F 1/32 Gavage 91 3c >256,000 (Griffiths 1979) 
36. 6-Hydroxydihydrotheaspirane Rat; M,F 1/32 Gavage 91 0.154c
 220,000 (Griffiths 1976) 
41. (-)-Sclareol Rat; M,F 1/20 Gavage 28 8.8c 88,000 (Merkel 2006) 
42. (+)-Cedrol Rat; M,F 1/20 Gavage 28 8.4c 280,000 (Merkel 2006) 
43. alpha-Bisabolol Rat; M,F 2/40 Gavage 28 < 1860
k
 3,100,000 (Habersang and others 1979) 
43. alpha-Bisabolol Dog; M,F 2/6 Gavage 28 < 1860k
,l
 3,100,000 (Habersang and others 1979) 
43. alpha-Bisabolol Rat; F 4/--c Gavage 10 931f >10,000 (Habersang and others 1979) 
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749   50 
43. alpha-Bisabolol Rabbit; F 4/--c Gavage 13 931f >10,000 (Habersang and others 1979) 
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Table 3. Studies of genotoxicity with aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances used as flavouring 751 
ingredients 752 
 753 
No. Flavouring agent End-point Test object Concentration Results Reference 
In vitro 
1 Linalool Reverse mutation Salmonella typhimurium. 
TA100 
0.01-3 µl/2 ml incubation 
volume 
Negative
a
 (Eder and others 1980) 
1 Linalool Reverse mutation Salmonella typhimurium 
TA92, TA100, TA1535, 
TA1537, TA94, TA98 
1 mg/plate Negativea (Ishidate and others 
1984) 
1 Linalool Reverse mutation Salmonella typhimurium 
TA98, TA100 
0.05-100 µl Negativea (Rockwell and Raw 
1979) 
1 Linalool Reverse mutation Salmonella typhimurium 
TA100, TA1535, TA1537, 
TA1538, TA98 
10,000 nl/plate Negativea (Heck and others 1989) 
                                                 
a With and without metabolic bioactivation system, S-9. 
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No. Flavouring agent End-point Test object Concentration Results Reference 
1 Linalool Reverse Mutation Escherichia coli WP2 
uvrA 
0.125-1 mg/plate Negative (Yoo 1986) 
1 Linalool Forward Mutation Mouse Lymphoma 
L5178Y TK+/- 
3.9-125 nl/ml 
100-300 nl/ml 
200 nl/ml 
25-150 nl/ml 
 
Negative
b
 
Weakly 
Positive
c
 
(Heck and others 1989) 
 
 
1 Linalool Unscheduled DNA 
Synthesis 
Rat hepatocytes 50 nl/ml 
43.1 µg/ml 
Negative (Heck and others 1989) 
1 Linalool Chromosomal 
aberration 
Chinese hamster 
fibroblasts 
250 µg/ml Negativec (Ishidate and others 
1984) 
1 Linalool Mutation Bacillus subtilis H17 
(rec+) & M45 (rec-) 
17 µg Negative (Oda and others 1978) 
1 Linalool Mutation Bacillus subtilis H17 
(rec+) & M45 (rec-) 
10 µl/disk 
8,620 µg/disc
 
Positive (Yoo 1986) 
                                                 
b With metabolic bioactivation system, S-9. 
c Without metabolic bioactivation system, S-9.  
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No. Flavouring agent End-point Test object Concentration Results Reference 
 
4 Linalyl acetate Reverse Mutation Salmonella  typhimurium 
TA1535, TA1537, 
TA1538, TA98, TA100 
25,000 nl/plate Negativea (Heck and others 1989) 
4 Linalyl acetate Unscheduled DNA 
Synthesis 
Fischer or SD rat 
hepatocytes 
300 nl/ml Negative (Heck and others 1989) 
4 Linalyl acetate Mutation Bacillus subtilis H17 
(rec+) & M45 (rec-) 
18 µg Negative (Oda and others 1978) 
4 Linalyl acetate Chromosomal 
aberration 
Human peripheral blood 
lymphocytes 
180 µg/ml Negative (Bertens 2000) 
5 Linalyl propionate Reverse Mutation Salmonella  typhimurium 
TA1535, TA1537, 
TA1538, TA98, TA100 
10-5,000 µg/plate Negative Sokolowski 2004 
11 alpha-Terpineol Reverse Mutation Salmonella  typhimurium 
TA1535, TA1537, 
TA1538, TA98, TA100 
10,000 µg/plate Negativea (Heck and others 1989) 
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No. Flavouring agent End-point Test object Concentration Results Reference 
11 alpha-Terpineol Reverse Mutation Salmonella  typhimurium 
TA1535, TA1537, TA98, 
TA100 
Up to 3 µmol/plate Negativea (Florin and others 1980) 
11 α-Terpineol Forward Mutation Mouse Lymphoma 
L5178Y TK+/- 
250 nl/ml 
300 nl/ml 
Negativeb 
Negativec 
(Heck and others 1989) 
13 Terpinyl acetate Mutation Bacillus subtilis H17 
(rec+) & M45(rec-) 
19 µg Negative (Oda and others 1978) 
20 p-Menth-8-en-1-ol 
(beta-Terpineol) 
Reverse Mutation Salmonella typhimurium 
TA100, TA98 
0.05-100 µl Negativea (Rockwell and Raw 
1979) 
 Terpineol Mutation Bacillus subtilis H17 
(rec+) & M45(rec-) 
19 µg Negativea (Oda and others 1978) 
27 1-Phenyl-3-methyl-
3-pentanol 
Reverse mutation Salmonella typhimurium 
TA1535, TA1537, 
TA1538, TA98, and 
TA100 
Up to 3,600 µg/plate Negativea (Wild and others 1983) 
31 alpha,alpha- Reverse mutation Salmonella typhimurium Up to 1,000 µg/plate Negativea (Asquith 1989) 
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No. Flavouring agent End-point Test object Concentration Results Reference 
Dimethylphenethyl 
formate 
TA1535, TA1537, TA98, 
and TA100 
42 (+)-Cedrol Reverse Mutation Salmonella typhimurium 
TA1535, TA97a, TA98, 
TA100 and TA102 
0, 1.6, 5, 16, 50, 160, 500, 
1,600, and 5,000 µg/plate 
Negativea
,d (Scheerbaum 2001) 
43 alpha-Bisabolol Reverse Mutation Salmonella typhimurium 
TA98, TA100, TA102, 
TA1535, TA 1537 
0, 1.5, 5, 15, 50, 100, 150 and 
500 µg/plate 
Negativea
,e,f
 (King 2002) 
43 alpha-Bisabolol Reverse Mutation Salmonella typhimurium 
TA100, TA97a, TA98 and 
TA1535 
0, 1, 5, 10, 25, 50, 100, 200, 300 
and 400 µg/plate 
Negativea
,d,g (Gomes-Carneiro and 
others 2005) 
In vivo 
1 Linalool Micronucleus 
Assay 
Male and Female Mice 
(Swiss CD-1) 
0, 500, 1000 and 1500 mg/kg 
bw
h
 
Negative (Meerts 2001) 
                                                 
d The test material was bacteriotoxic towards all strains at greater than or equal to 500 and 160 µg/plate with and without S-9 activation. 
e The test material was bacteriotoxic towards all strains at doses greater than or equal to 500 and 150 µg/plate with and without S-9 activation. 
f Standard plate incorporation method 
g The test material was bacteriotoxic towards all strains at greater than 200 and100 µg/plate with and without S-9 activation. 
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No. Flavouring agent End-point Test object Concentration Results Reference 
27 1-Phenyl-3-methyl-
3-pentanol 
Sex-linked 
recessive lethal 
mutation (Basc 
test) 
Drosophila melanogaster 0 or 20 mM 
(3,565 µg/ml)
i
 
Negative (Wild and others 1983) 
27 1-Phenyl-3-methyl-
3-pentanol 
Micronucleus 
induction 
NMRI Mice 0, 357, 624, 891, or 1,416 mg/kg 
bw 
Negative (Wild and others 1983) 
                                                                                                                                                                                                                         
h Administered via gavage. 
i Calculated using molecular weight of 1-Phenyl-3-methyl-3-pentanol = 178.28 
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OH
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CYP-450
 754 
Figure 1.  Metabolism of linalool in mammals. 755 
756 
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reduction
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OH
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 757 
 Figure 2. Metabolism of α-terpineol in rats 758 
 759 
760 
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 762 
 Figure 3.  Metabolism of trans-Sobrerol in rats, dogs, and humans 763 
 764 
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